Register Login

MEIRAGTX HOLDINGS PLC (MGTX)

(90% Positive) MEIRAGTX HOLDINGS PLC (MGTX) Announces Enrollment Update for seen Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot April 16, 2026, 11:09 a.m.

    📋 MEIRAGTX HOLDINGS PLC (MGTX) - Clinical Trial Update

    Filing Date: 2026-04-16

    Accepted: 2026-04-16 07:09:05

    Event Type: Clinical Trial Update

    Event Details:

    MEIRAGTX HOLDINGS PLC (MGTX) Announces Clinical Trial Update MEIRAGTX HOLDINGS PLC (MGTX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: seen
    • Clinical Stage: Phase 1, Clinical Study
    • Collaboration: PRO Xerostomia Questionnaire

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: MEIRAGTX HOLDINGS PLC
    • Ticker Symbol: MGTX

Search

News categories